Neurotech International Ltd.

Last Updated:
12:28 pm
Thursday, June 26, 2025
Neurotech International Ltd. engages in the research, design, development, and manufacture of medical devices and solutions in Australia. Its product includes Mente Autism for the diagnosis and treatment of autism. The company was founded on January 15, 2016 and is headquartered in Nedlands, Australia.
Market Cap
AU$17.84M
Volume
1338281
Open
0.02
AU$
High
0.02
AU$
Low
0.01
AU$
Shares On Issue
1.02B
52 Week Low
0.015
AU$
52 Week High
0.093
AU$
Website
www.neurotechinternational.com
Sector
Healthcare
Medical Specialties
Consensus
N/A
Last Report Date
N/A
Next Report Date
N/A
Next Dividend date
N/A
Short Sell
N/A
Short Sell Change (1mth)
N/A
Free ASX Market Outlook & Top Stock Picks for 2025
Instantly access our exclusive report and see which stocks our analysts are backing for growth this year.
Download Free Report

Related

Our friendly team is here to help.

If you have any questions or feedback about our service, please feel free to contact us.